Bioactive Compounds
-
A3514 JAK2 Inhibitor V, Z3Summary: Jak2 tyrosine kinase inhibitor -
A3518 JDTic 2HClSummary: κ-opioid receptor antagonist -
A3519 JNK-IN-7Target: JNKSummary: Selective JNK inhibitor -
A3530 KN-92 hydrochlorideTarget: Ca2 /calmodulin-dependent protein kinases (CaMKs)Summary: Inactive derivative of KN-93,control compound -
A3535 KX2-391 dihydrochlorideTarget: SrcSummary: Src kinase, tubulin polymerization, HBV transcription, and botulinum neurotoxin A (BoNT/A) inhibitor -
A3536 L-165041Target: PPARSummary: PPARβ/δ agonist,cell permeable,potent and selective -
A3544 LDK378 dihydrochlorideSummary: ALK inhibitor -
A3592 Medetomidine1 CitationSummary: α2-adrenoceptor agonist -
A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: A competitive, reversible glucagon receptor (GCGR) antagonist -
A3626 ML-7 hydrochlorideTarget: Myosin light chain kinases (MLCKs)Summary: Myosin light chain kinase inhibitor

